Efficacy and Safety of Deferasirox (Exjade (R)) in Reducing Cardiac Iron in Patients with beta-Thalassemia Major: Results from the Cardiac Substudy of the EPIC Trial
dc.contributor.author | Pennell, Dudley | |
dc.contributor.author | Porter, John B. | |
dc.contributor.author | Cappellini, Maria Domenica | |
dc.contributor.author | Li, Chi-Kong | |
dc.contributor.author | Aydinok, Yesim | |
dc.contributor.author | Lee, Chan Lee | |
dc.contributor.author | Kattamis, Antonis | |
dc.contributor.author | Smith, Gillian | |
dc.contributor.author | Habr, Dany | |
dc.contributor.author | Domokos, Gabor | |
dc.contributor.author | Hmissi, Abdel | |
dc.contributor.author | Taher, Ali | |
dc.date.accessioned | 2019-10-27T20:22:56Z | |
dc.date.available | 2019-10-27T20:22:56Z | |
dc.date.issued | 2008 | |
dc.department | Ege Üniversitesi | en_US |
dc.description | 50th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2008 -- San Francisco, CA | en_US |
dc.description.sponsorship | Amer Soc Hematol | en_US |
dc.identifier.endpage | 1318 | en_US |
dc.identifier.issn | 0006-4971 | |
dc.identifier.issue | 11 | en_US |
dc.identifier.startpage | 1318 | en_US |
dc.identifier.uri | https://hdl.handle.net/11454/41961 | |
dc.identifier.volume | 112 | en_US |
dc.identifier.wos | WOS:000262104704480 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Amer Soc Hematology | en_US |
dc.relation.ispartof | Blood | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Efficacy and Safety of Deferasirox (Exjade (R)) in Reducing Cardiac Iron in Patients with beta-Thalassemia Major: Results from the Cardiac Substudy of the EPIC Trial | en_US |
dc.type | Conference Object | en_US |